Notably, markers of chronic inflammation, such as CD3 receptors or CD68, are strongly correlated with NKX3.1 status in human prostate tumors, which is not the case for markers of acute inflammation such as CEACAM8 or CD177. Here, CD68 is linked to prostate neoplasm.